GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

basiliximab   Click here for help

GtoPdb Ligand ID: 6879

Synonyms: CHI-621 | L04AC02 | SDZ-CHI-621 | Simulect®
Approved drug Immunopharmacology Ligand
basiliximab is an approved drug (FDA (1998), EMA (1998))
Compound class: Antibody
Comment: Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: basiliximab

No information available.
Summary of Clinical Use Click here for help
Prophylaxis of acute organ rejection in adults following cadaveric- or living-donor renal transplantation
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Abrogates the critical cellular immune response involved in allograft rejection by acting as a functional IL-2 receptor antagonist, thereby inhibiting IL-2-mediated activation of lymphocytes.
External links Click here for help
For extended ADME data see the following:

Electronic Medicines Compendium (eMC)
Drugs.com
European Medicines Agency (EMA)